SCHEMBL14756265

SCHEMBL14756265

CCCNN=N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14647522 0.83
SCHEMBL15203074 0.81
SCHEMBL14375478 0.79
SCHEMBL15783005 0.79 CYP2C19 (0.42)
SCHEMBL15958733 0.77 EPHX1 (0.48)
SCHEMBL17399221 0.73 TSHR (0.48)
SCHEMBL4886500 0.72 ADH1B (0.33)
SCHEMBL15782750 0.71 CYP2C19 (0.46)
SCHEMBL17399225 0.71
SCHEMBL17705678 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2488178-B1 COMBINATIONS OF A PI3K INHIBITOR AND A MEK INHIBITOR HOFFMANN LA ROCHE (CH) 2016-11-16 EP disclosed
EP-2766370-B1 COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF RESPIRATORY SYNCYTIAL VIRUS DISEASE HOFFMANN LA ROCHE (CH) 2016-08-03 EP disclosed
EP-2833966-B1 TETHERED IMPLANTABLE MEDICAL DEVICE DEPLOYMENT MEDTRONIC INC (US) 2016-05-18 EP disclosed
US-20160102297-A1 RESTRICTIVE INVERTED TERMINAL REPEATS FOR VIRAL VECTORS UNIV NORTH CAROLINA (US) 2016-04-14 US disclosed
EP-2124951-B1 5-CYAN0-4- (PYRROLO[2, 3B]PYRIDINE-3-YL) -PYRIMIDINE DERIVATIVES USEFUL AS PROTEIN KINASE INHIBITORS VERTEX PHARMA (US) 2014-05-21 EP disclosed
WO-2013033268-A2 BIVALENT BROMODOMAIN LIGANDS, AND METHODS OF USING SAME COFERON, INC. (US) 2013-03-07 WO disclosed